Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

argenx SE - American Depositary Shares (NQ:ARGX)

913.02 +0.56 (+0.06%)
Streaming Delayed Price Updated: 10:28 AM EDT, Jun 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about argenx SE - American Depositary Shares

< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
News headline image
argenx to Present at Upcoming Investor Conferences
From argenx SE
Via GlobeNewswire
News headline image
Top AI Stock ANET Leads 5 Stocks Near Buy Points In Tough Market ↗
Arista Networks and Dutch biotech Argenx lead this weekend's watch list. 
Via Investor's Business Daily
Topics Artificial Intelligence
News headline image
Here's How Much You Would Have Made Owning argenx Stock In The Last 5 Years ↗
 
Via Benzinga
News headline image
$1000 Invested In argenx 5 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
Is Argenx Stock a Buy Now? ↗
Good news keeps rolling in for the biotech. 
Via The Motley Fool
News headline image
argenx Reports Half Year 2023 Financial Results and Provides Second Quarter Business Update
From argenx SE
Via GlobeNewswire
News headline image
Earnings Outlook For argenx ↗
 
Via Benzinga
News headline image
argenx Unusual Options Activity ↗
 
Via Benzinga
News headline image
Why Shares of Argenx Jumped This Week ↗
The company's lead therapy showed progress in treating an autoimmune disorder. 
Via The Motley Fool
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 31, 2023 ↗
 
Via Benzinga
News headline image
Argenx Stock Rides 'Megabuster' Drug Excitement To 40% Gain Before Earnings ↗
Argenx is up around 40% in 2023 after shares soared nearly 30% in a single day last week. 
Via Investor's Business Daily
News headline image
argenx announces closing of global offering
From argenx SE
Via GlobeNewswire
News headline image
The Latest Analyst Ratings for argenx ↗
 
Via Benzinga
News headline image
If You Invested $100 In This Stock 5 Years Ago, You Would Have $500 Today ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 24, 2023 ↗
 
Via Benzinga
News headline image
Dow Jones Leads Market Advance As Tesla, Netflix, Taiwan Semiconductor Hit Growth: Weekly Review ↗
But all the major indexes are at or near 15-month highs. 
Via Investor's Business Daily
News headline image
Why Argenx Stock Is on Fire Today ↗
A major clinical win is boosting the drugmaker's shares today. 
Via The Motley Fool
News headline image
Amicus Therapeutics Stock Scores Healthy Relative Strength Upgrade ↗
On Thursday, Amicus Therapeutics stock got an upgrade to its Relative Strength (RS) Rating, from 78 to 81. 
Via Investor's Business Daily
News headline image
argenx to Report Half Year 2023 Financial Results and Second Quarter Business Update on July 27, 2023
From argenx SE
Via GlobeNewswire
News headline image
argenx announces full exercise of underwriters’ option to purchase additional ADSs
From argenx SE
Via GlobeNewswire
News headline image
argenx raises $1.1 billion in gross proceeds in a global offering
From argenx SE
Via GlobeNewswire
News headline image
Immunovant's FcRn Strategy Gains Momentum: Analysts View ADHERE Study as De-Risking Factor for CIDP Clinical Development ↗
Monday, Argenx SE (NASDAQ: ARGX) reported topline results from the ADHERE study evaluating Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) in adults with chronic inflammatory demyelinating... 
Via Benzinga
News headline image
argenx announces launch of proposed global offering
From argenx SE
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
Why Acumen Pharmaceuticals Shares Are Trading Higher By Over 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Gainers ProMIS Neurosciences, Inc. (NASDAQ: PMN) shares jumped 126.6% to $6.37. ProMIS showcased preclinical data at the Alzheimer's Association International Conference 2023 on computationally-derived... 
Via Benzinga
argenx SE (NASDAQ: ARGX) Leading the Way in Monday Trading Based on Percentage Gain
Via Investor Brand Network
News headline image
Argenx Catapults 27% To Record High As It Edges Closer To A New Multibillion-Dollar Market ↗
Vyvgart is already approved in multiple diseases. But Argenx isn't stopping there. 
Via Investor's Business Daily
News headline image
You Can't Afford to Miss Monday's 2 Nasdaq Biotech Stock Movers ↗
Big gains are afoot even as the markets prepare for a flat open. 
Via The Motley Fool
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why BYND Cannasoft Enterprises Shares Are Trading Lower By 40%; Here Are 20 Stocks Moving Premarket ↗
Gainers 
Via Benzinga
< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.